Devallière et al., 2012 - Google Patents
LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migrationDevallière et al., 2012
View HTML- Document ID
- 3100356866133293992
- Author
- Devallière J
- Chatelais M
- Fitau J
- Gérard N
- Hulin P
- Velazquez L
- Turner C
- Charreau B
- Publication year
- Publication venue
- The FASEB Journal
External Links
Snippet
Focal adhesion (FA) formation and disassembly play an essential role in adherence and migration of endothelial cells. These processes are highly regulated and involve various signaling molecules that are not yet completely identified. Lnk [Src homology 2-B3 (SH2B3)] …
- 101700057660 SH2B3 0 title abstract description 255
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Devallière et al. | LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration | |
| Tang et al. | Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition | |
| Piao et al. | AMPA receptors promote perivascular glioma invasion via β1 integrin–dependent adhesion to the extracellular matrix | |
| Huang et al. | Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting | |
| Sheng et al. | The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis | |
| Bruzzaniti et al. | Dynamin forms a Src kinase–sensitive complex with Cbl and regulates podosomes and osteoclast activity | |
| Rintoul et al. | Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth | |
| Sotgia et al. | Caveolin-1-Deficient Mice Have An Increased Mammary Stem Cell Population with Upregulation of Wnt/?-Catenin Signaling | |
| Dassah et al. | Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells | |
| Romani et al. | RETRACTED ARTICLE: Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces | |
| Johnston et al. | β3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy | |
| Shin et al. | VDUP1 mediates nuclear export of HIF1α via CRM1-dependent pathway | |
| Ambesi et al. | Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G1 arrest in human microvessel endothelial cells | |
| Jiang et al. | Ang II–stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice | |
| Wong et al. | Protogenin defines a transition stage during embryonic neurogenesis and prevents precocious neuronal differentiation | |
| Samarelli et al. | Rabgap1 promotes recycling of active β1 integrins to support effective cell migration | |
| Fournier et al. | Nuclear translocation of integrin cytoplasmic domain-associated protein 1 stimulates cellular proliferation | |
| Amado-Azevedo et al. | Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation | |
| Loughlin et al. | 3‐Deoxyglucosone‐collagen alters human dermal fibroblast migration and adhesion: Implications for impaired wound healing in patients with diabetes | |
| Nayak et al. | Regulation of ovarian cancer G protein-coupled receptor-1 expression and signaling | |
| An et al. | Soluble LILRA3 promotes neurite outgrowth and synapses formation through a high-affinity interaction with Nogo 66 | |
| Lu et al. | C/EBPα‐mediated transcriptional activation of PIK3C2A regulates autophagy, matrix metalloproteinase expression, and phenotypic of vascular smooth muscle cells in aortic dissection | |
| Qiu et al. | Id1-induced inhibition of p53 facilitates endothelial cell migration and tube formation by regulating the expression of beta1-integrin | |
| Yund et al. | Hic-5 is required for fetal gene expression and cytoskeletal organization of neonatal cardiac myocytes | |
| Lin et al. | Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca2+ leakage channel Sec61α in mouse hearts |